The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 609-614

  Harris, Eleanor E R ^a   Freilich, Jessica ^a   Lin, Hui Yi ^a   Chuong, Michael ^a   Acs, Geza ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY NODES; BREAST CANCER; CONFIDENCE INTERVAL; CUMULATIVE INCIDENCE; HIGH-RISK PATIENTS; MULTI VARIABLES; NODAL METASTASIS; POSITIVE LYMPH NODES; POSTMASTECTOMY RADIATION THERAPIES; SYSTEMIC THERAPY;

DISEASES; RADIOTHERAPY;

PATHOLOGY;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMASTECTOMY RADIATION THERAPY; PRIORITY JOURNAL; RECURRENCE RISK;

ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN;

EID: 84873299990     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.05.050     Document Type: Article

References (20)

1. J.R. Harris, P. Halpin-Murphy, and M. McNeese Consensus statement on postmastectomy radiation therapy Int J Radiat Oncol Biol Phys 44 1999 989 990
2. P. Eifel, J.A. Axelson, and J. Costa National Institute of Health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000 J Natl Cancer Inst 93 2000 979 989
3. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B and C randomized trials Radiother Oncol 82 2007 247 253
4. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
5. M. Overgaard, P.S. Hansen, and J. Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 337 1997 949 955
6. T. Buchholz, W. Woodward, and Z. Duan Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes Int J Radiat Oncol Biol Phys 71 2008 1022 1027
7. J.C.H. Cheng, C.M. Chen, and M.C. Liu Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy Int J Radiat Oncol Biol Phys 52 2002 980 988
8. A. Katz, E.A. Strom, and T.A. Buchholz Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation J Clin Oncol 18 2000 2817 2827
9. P.T. Truong, I.A. Olivotto, and H.A. Kader Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1337 1347
10. T.J. Whelan, I. Olivotto, and J.W. Ackerman NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer [Abstract] J Clin Oncol 29 suppl 2011 779s
11. P.T. Truong, E. Berthelet, and J. Lee The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes Cancer 103 2005 2006 2014
12. I.L. Atahan, F. Yildiz, and G. Ozyigit Percent positive axillary lymph metastasis predicts survival in patients with non-metastatic breast cancer Acta Oncol 47 2008 232 238
13. J.I. Yu, W. Park, and S.J. Huh Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer Int J Radiat Oncol Biol Phys 78 2010 1135 1141
14. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
15. H.T. Kim Cumulative incidence in competing risks data and competing risks regression analysis Clin Cancer Res 13 pt 1 2007 559 565
16. J.W. Chapman, E.B. Fish, and M.A. Link Competing risks analyses for recurrence from primary breast cancer Br J Cancer 79 1999 1508 1513
17. R.J. Gray A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
18. S.S. Park, I.S. Grills, and L.L. Kestin Ten year outcomes for regional nodal failure in early stage breast cancer patients treated with breast conserving therapy Int J Radiat Oncol Biol Phys 75 2009 3S 186
19. R. Sharma, I. Bedrosian, and L. Lucci Present-day locoregional control in patients with T1 or Y2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy Ann Surg Oncol 17 2010 2899 2908
20. L. Yates, A. Kirby, and S. Crichton Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes Int J Radiat Oncol Biol Phys 82 2012 2093 2103